INTERNATIONAL PATENT: AFFIMED GMBH FILES APPLICATION FOR "CD16A/TUMOR ANTIGEN POLYSPECIFIC BINDER FOR USE IN THE TREATMENT OF IMMUNE CHECKPOINT INHIBITOR RESISTANCE"

GENEVA, Dec. 22 -- AFFIMED GMBH (KOROS buildingGottlieb-Daimler-StraBe 268165 Mannheim) filed a patent application (PCT/IB2024/055675) for "CD16A/TUMOR ANTIGEN POLYSPECIFIC BINDER FOR USE IN THE TREATMENT OF IMMUNE CHECKPOINT INHIBITOR RESISTANCE" on Jun 10, 2024. With publication no. WO/2025/257588, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): RAJKOVIC, Erich (KOROS buildingGottlieb-Daimler-Strasse 268165 Mannheim), DULAT, Holger (KOROS buildingGottlieb-Daimler-Strasse 268165 Mannheim), MORALES-ESPINOSA, Daniela (KORO...